Second half report. A little late (#workingmom). The second half of the FDA meeting started off with public comment. There was one major theme: vaccine hesitancy. A legitimate concern public health officials need to consider while rolling out the vaccine campaign.
FDA meeting (part 2)
FDA meeting (part 2)
FDA meeting (part 2)
Second half report. A little late (#workingmom). The second half of the FDA meeting started off with public comment. There was one major theme: vaccine hesitancy. A legitimate concern public health officials need to consider while rolling out the vaccine campaign.